Computational fragment-based drug design of potential Glo-I inhibitors
In this study, a fragment-based drug design approach, particularly de novo drug design, was implemented utilising three different crystal structures in order to discover new privileged scaffolds against glyoxalase-I enzyme as anticancer agents. The fragments were evoluted to indicate potential inhib...
Saved in:
| Main Authors: | Roaa S. Bibars, Qosay A. Al-Balas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2024.2301758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fragmenstein: predicting protein–ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding–based methodology
by: Matteo P. Ferla, et al.
Published: (2025-01-01) -
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
by: Al-Shar’i Nizar A., et al.
Published: (2021-03-01) -
Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy
by: Ahrum Son, et al.
Published: (2024-11-01) -
Perspectives on Applications of <sup>19</sup>F-NMR in Fragment-Based Drug Discovery
by: Qingxin Li, et al.
Published: (2024-12-01) -
Generation of Rational Drug-like Molecular Structures Through a Multiple-Objective Reinforcement Learning Framework
by: Xiangying Zhang, et al.
Published: (2024-12-01)